HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES

Nima Sharifi, Arun A. Azad, Mona Patel, Jason W.D. Hearn, Michele Wozniak, Fabian Zohren, Jennifer Sugg, Gabriel P. Haas, Arnulf Stenzl, Andrew J. Armstrong

Open source

DOI: 10.1016/j.xcrm.2024.101644
Published: 2024-08
Container: Cell Reports Medicine
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.xcrm.2024.101644,
  title = {HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES},
  author = {Nima Sharifi and Arun A. Azad and Mona Patel and Jason W.D. Hearn and Michele Wozniak and Fabian Zohren and Jennifer Sugg and Gabriel P. Haas and Arnulf Stenzl and Andrew J. Armstrong},
  year = {2024},
  journal = {Cell Reports Medicine},
  doi = {10.1016/j.xcrm.2024.101644},
  url = {https://doi.org/10.1016/j.xcrm.2024.101644}
}

RIS

TY  - JOUR
TI  - HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES
AU  - Nima Sharifi
AU  - Arun A. Azad
AU  - Mona Patel
AU  - Jason W.D. Hearn
AU  - Michele Wozniak
AU  - Fabian Zohren
AU  - Jennifer Sugg
AU  - Gabriel P. Haas
AU  - Arnulf Stenzl
AU  - Andrew J. Armstrong
PY  - 2024
JO  - Cell Reports Medicine
DO  - 10.1016/j.xcrm.2024.101644
UR  - https://doi.org/10.1016/j.xcrm.2024.101644
ER  -

APA

Sharifi, N., Azad, A. A., Patel, M., Hearn, J. W., Wozniak, M., Zohren, F., Sugg, J., Haas, G. P., Stenzl, A., & Armstrong, A. J. (2024). HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES. Cell Reports Medicine. https://doi.org/10.1016/j.xcrm.2024.101644

Source records

crossref · retrieved 2026-09-26T14:58:36.735Z